Biogen, Inc.
(NASDAQ : BIIB)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 6.84%170.810.0%$1433.85m
AMGNAmgen, Inc. 0.23%255.711.3%$690.21m
NVAXNovavax, Inc. 12.50%227.3580.0%$655.57m
SNSSSunesis Pharmaceuticals, Inc. -0.37%8.000.7%$559.23m
ILMNIllumina, Inc. -0.74%399.003.5%$519.65m
GILDGilead Sciences, Inc. 1.67%66.871.0%$470.50m
REGNRegeneron Pharmaceuticals, Inc. 1.61%502.602.7%$458.74m
VRTXVertex Pharmaceuticals, Inc. -0.77%219.391.9%$388.60m
ALXNAlexion Pharmaceuticals, Inc. 3.90%163.682.0%$348.10m
BNTXBioNTech SE 7.69%151.540.0%$313.57m
BIIBBiogen, Inc. -0.05%270.311.7%$263.29m
EXASEXACT Sciences Corp. -0.37%130.0418.4%$186.19m
NBIXNeurocrine Biosciences, Inc. 1.66%96.584.9%$179.73m
CRSPCRISPR Therapeutics AG -4.27%118.560.6%$166.57m
SGENSeagen Inc. -2.77%145.505.8%$146.84m

Company Profile

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. It offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for the treatment of multiple sclerosis; SPINRAZA for the treatment of spinal muscular atrophy; and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.